Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

Briefly

Wayne Kondro
CMAJ August 12, 2008 179 (4) 318; DOI: https://doi.org/10.1503/cmaj.081032
Wayne Kondro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Class action approvals: The Quebec Superior Court has approved a $50 million suit against Pfizer Inc. related to its contraceptive Depo-Provera, which allegedly causes a decrease in bone density in women. Meanwhile, the Saskatchewan Court of Queen's Bench has expanded a suit against Merck Frosst Canada Ltd. to allow non-residents of the province (except Quebecers) to join their action against the drug rofecoxib (Vioxx). In November 2007, Merck & Co. agreed to a US$4.85 billion settlements for rofecoxib plaintiffs in the United States.

2,4-D safe: Health Canada's Pest Management Regulatory Agency says a scientific re-evaluation of the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) has concluded that it poses no risks to the health of children, adults, animals or the environment when used according to label instructions.

Antiretroviral access: About 3 million people had access to antiretroviral therapy in low-and middle-income countries in 2007, comprising roughly 31% of the 9.7 million who now need the life-saving HIV drugs, according to a new report (www.who.int) from the World Health Organization, UNAIDS and UNICEF. Although it took 2 years longer than once planned to achieve the “3 by 5” target, WHO Director-General Dr. Margaret Chan called it “a remarkable achievement for public health.”

Discarded needles: The city of Ottawa will spend $100 000 over the course of the summer of 2008 to hire summer students, who'll roam streets and parks picking up discarded drug needles, which critics say are littering the streets of the national capital as a result of a program to distribute some 343 000 needles a year. City council also launched a $50 000 safe syringe study.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Photo by: Pete Birkinshaw

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 179 (4)
CMAJ
Vol. 179, Issue 4
12 Aug 2008
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Briefly
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Briefly
Wayne Kondro
CMAJ Aug 2008, 179 (4) 318; DOI: 10.1503/cmaj.081032

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Briefly
Wayne Kondro
CMAJ Aug 2008, 179 (4) 318; DOI: 10.1503/cmaj.081032
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Saying goodbye to CMAJ News
  • How Canadian hospitals are decreasing carbon emissions
  • National survey highlights worsening primary care access
Show more News

Similar Articles

Collections

  • Topics
    • Canadian government
    • Global health

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

CMA Civility, Accessibility, Privacy

 

Powered by HighWire